This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kraft, H. G. Articles by Utermann, G. Search for Related Content PubMed PubMed Citation Articles by Kraft, H. G. Articles by Utermann, G. Pubmed/NCBI databases Substance via MeSH Genetics Home Reference Related Collections Risk Factors Genetics of cardiovascular disease Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:522.)
© 2000 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Lipoprotein(a) in Homozygous Familial Hypercholesterolemia

H. G. Kraft; A. Lingenhel; F. J. Raal; M. Hohenegger; G. Utermann

From the Institute for Medical Biology and Human Genetics (H.G.K., A.L., M.H., G.U.), University of Innsbruck, Innsbruck, Austria, and the Department of Medicine (F.J.R.), University of Witwatersrand, Johannesburg, South Africa.

Correspondence to Univ Prof Dr H.G. Kraft, Institute for Med. Biology and Human Genetics, Schöpfstr 41, A-6020 Innsbruck, Austria. E-mail Hans-Georg.Kraft{at}uibk.ac.at

Abstract—Lipoprotein(a) [Lp(a)] is a quantitative genetic trait that in the general population is largely controlled by 1 major locus—the locus for the apolipoprotein(a) [apo(a)] gene. Sibpair studies in families including familial defective apolipoprotein B or familial hypercholesterolemia (FH) heterozygotes have demonstrated that, in addition, mutations in apolipoprotein B and in the LDL receptor (LDL-R) gene may affect Lp(a) plasma concentrations, but this issue is controversial. Here, we have further investigated the influence of mutations in the LDL-R gene on Lp(a) levels by inclusion of FH homozygotes. Sixty-nine members of 22 families with FH were analyzed for mutations in the LDL-R as well as for apo(a) genotypes, apo(a) isoforms, and Lp(a) plasma levels. Twenty-six individuals were found to be homozygous for FH, and 43 were heterozygous for FH. As in our previous analysis, FH heterozygotes had significantly higher Lp(a) than did non-FH individuals from the same population. FH homozygotes with 2 nonfunctional LDL-R alleles had almost 2-fold higher Lp(a) levels than did FH heterozygotes. This increase was not explained by differences in apo(a) allele frequencies. Phenotyping of apo(a) and quantitative analysis of isoforms in family members allowed the assignment of Lp(a) levels to both isoforms in apo(a) heterozygous individuals. Thus, Lp(a) levels associated with apo(a) alleles that were identical by descent could be compared. In the resulting 40 allele pairs, significantly higher Lp(a) levels were detected in association with apo(a) alleles from individuals with 2 defective LDL-R alleles compared with those with only 1 defective allele. This difference of Lp(a) levels between allele pairs was present across the whole size range of apo(a) alleles. Hence, mutations in the LDL-R demonstrate a clear gene-dosage effect on Lp(a) plasma concentrations.

Key Words: lipoprotein(a) • apolipoprotein(a) • familial hypercholesterolemia • homozygous familial hypercholesterolemia • low density lipoprotein receptors

This article has been cited by other articles:

				G. Miltiadous, V. Saougos, M. Cariolou, and M. S. Elisaf Plasma Lipoprotein(a) Levels and LDL-Cholesterol Lowering Response to Statin Therapy in Patients with Heterozygous Familial Hypercholesterolemia Ann. Clin. Lab. Sci., January 1, 2006; 36(3): 353 - 355. [Abstract] [Full Text] [PDF]

				S. Canizales-Quinteros, C. A. Aguilar-Salinas, E. Reyes-Rodriguez, L. Riba, M. Rodriguez-Torres, S. Ramirez-Jimenez, A. Huertas-Vazquez, V. Fragoso-Ontiveros, A. Zentella-Dehesa, J. L. Ventura-Gallegos, et al. Locus on Chromosome 6p Linked to Elevated HDL Cholesterol Serum Levels and to Protection Against Premature Atherosclerosis in a Kindred With Familial Hypercholesterolemia Circ. Res., March 21, 2003; 92(5): 569 - 576. [Abstract] [Full Text] [PDF]

				S. Gonbert, B. Saint-Jore, P. Giral, C. Doucet, J. Chapman, and J. Thillet Molecular Analysis of Apo(a) Fragmentation in Polygenic Hypercholesterolemia: Characterization of a New Plasma Fragment Pattern Arterioscler Thromb Vasc Biol, August 1, 2001; 21(8): 1353 - 1358. [Abstract] [Full Text] [PDF]